Data. by Saeedeh Abbasi (9423189)

“…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”

Changes in body weight and glycolipid metabolism in different groups. by Shujuan Hu (22656045)

Subjects:

Morphological changes of skeletal muscle, fat and liver in each group. by Shujuan Hu (22656045)

Subjects:

Effects of aerobic exercise on the expression levels of NLRP3 and its related factors in the skeletal muscle of mice. by Shujuan Hu (22656045)

Subjects:

Potential mechanism of aerobic exercise in regulating glycolipid metabolism of PDM mice. by Shujuan Hu (22656045)

Subjects:

The expression of irisin, NLRP3 and inflammation-related factors in C2C12 cells. by Shujuan Hu (22656045)

Subjects:

Flow chart. by Shujuan Hu (22656045)

Subjects:

Changes of metabolic indexes in the PDM group and DC group. by Shujuan Hu (22656045)

Subjects:

Sequences of primers used for qRT-PCR. by Shujuan Hu (22656045)

Subjects:

Raw data. by Jia Zhu (135506)

“…Biomechanical results revealed that the ROM of the surgical segment had decreased significantly under six basic working conditions following NZ implantation. …”

Table 1_Body mass index influences Antimüllerian Hormone and inhibin B in adult males.xls by Wen Zhou (49050)

“…However, due to the low effect size of BMI/AMH, caution is needed in interpreting its clinical significance. Although we found a non-linear relationship and key thresholds between these variables, further studies with larger sample sizes are needed to confirm these findings.…”

Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study by Klaus G. Parhofer (12280424)

“…LDL cholesterol (LDL-C) changes and factors influencing lipid-lowering therapy (LLT) intensification were assessed after one year. …”

Clustering analysis of total and active RNAP II at genes during the transition from G1 to G2. by Douglas Maya-Miles (7024967)

(A) Cost-effectiveness plane in healthcare system perspectives; (B) Cost-effectiveness acceptability curve in healthcare system perspectives; (C) Cost-effectiveness plane in societ... by Jae-Heung Cho (798319)

Subjects:

Primary and secondary outcomes by treatment and time since randomization. by Jae-Heung Cho (798319)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited pupicidal activity against pupae of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

S1 Data - by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited adulticidal activity against adult of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Quality of life years after randomization into the <i>Chuna</i> manual therapy and usual care groups. by Jae-Heung Cho (798319)

Subjects:

The response of the <i>A</i>. <i>albopictus</i> larval Glutathione S-transferase (GST) enzyme increased 7.8-fold in response to <i>M</i>. <i>robertsii</i>-derived copper nanopartic... by Perumal Vivekanandhan (4863484)

Subjects: